(-)-Epicatechin and NADPH oxidase inhibitors prevent bile acid-induced Caco-2 monolayer permeabilization through ERK1/2 modulation

Autor: Michael Müller, Patricia I. Oteiza, Ziwei Wang, M. Corina Litterio, David Vauzour
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Male
High fat
Clinical Biochemistry
Deoxycholic acid
Medical Biochemistry and Metabolomics
Occludin
Biochemistry
Catechin
Oral and gastrointestinal
chemistry.chemical_compound
Mice
0302 clinical medicine
ERK
extracellular signal-regulated kinase

MLC
myosin light chain

MLCK
MLC kinase

Intestinal Mucosa
Enzyme Inhibitors
lcsh:QH301-705.5
Epicatechin
lcsh:R5-920
Benzoxazoles
EC
(-)-epicatechin

NADPH oxidase
biology
Bile acid
Pharmacology and Pharmaceutical Sciences
GI
gastrointestinal

NOX
NADPH oxidase

Cell biology
MMP
matrix metalloproteinase

TJ
tight junction

EGFR
EGF receptor

lcsh:Medicine (General)
Research Paper
Myosin light-chain kinase
medicine.drug_class
MAP Kinase Signaling System
DCFDA
5-(and-6)-carboxy-2′7′-dichlorodihydrofluorescein diacetate

Phosphatase
Intestinal permeability
Diet
High-Fat

Permeability
MEM
minimum essential medium

Bile Acids and Salts
03 medical and health sciences
ROS
reactive oxygen species

medicine
Animals
Humans
Nutrition
EGF
epidermal growth factor

Prevention
Organic Chemistry
Acetophenones
NADPH Oxidases
Triazoles
Bile acids
Diet
High-Fat
030104 developmental biology
DCA
deoxycholic acid

lcsh:Biology (General)
chemistry
Caco-2
Apocynin
biology.protein
Biochemistry and Cell Biology
Caco-2 Cells
Digestive Diseases
DHE
dihydroethidium

030217 neurology & neurosurgery
Zdroj: Redox Biology, Vol 28, Iss, Pp-(2020)
Redox Biology
Popis: Secondary bile acids promote gastrointestinal (GI) tract permeabilization both in vivo and in vitro. Consumption of high fat diets increases bile acid levels in the GI tract which can contribute to intestinal permeabilization and consequent local and systemic inflammation. This work investigated the mechanisms involved in bile acid (deoxycholic acid (DCA))-induced intestinal epithelial cell monolayer permeabilization and the preventive capacity of (-)-epicatechin (EC). While EC prevented high fat diet-induced intestinal permeabilization in mice, it did not mitigate the associated increase in fecal/cecal total and individual bile acids. In vitro, using differentiated Caco-2 cells as a model of epithelial barrier, EC and other NADPH oxidase inhibitors (VAS-2870 and apocynin) mitigated DCA-induced Caco-2 monolayer permeabilization. While EC inhibited DCA-mediated increase in cell oxidants, it did not prevent DCA-induced mitochondrial oxidant production. Prevention of DCA-induced ERK1/2 activation with EC, VAS-2870, apocynin and the MEK inhibitor U0126, also prevented monolayer permeabilization, stressing the key involvement of ERK1/2 in this process and its redox regulation. Downstream, DCA promoted myosin light chain (MLC) phosphorylation which was related to MLC phosphatase (MLCP) inhibition by ERK1/2. DCA also decreased the levels of the tight junction proteins ZO-1 and occludin, which can be related to MMP-2 activation and consequent ZO-1 and occludin degradation. Both events were prevented by EC, NADPH oxidase and ERK1/2 inhibitors. Thus, DCA-induced Caco-2 monolayer permeabilization occurs mainly secondary to a redox-regulated ERK1/2 activation and downstream disruption of TJ structure and dynamic. EC's capacity to mitigate in vivo the gastrointestinal permeabilization caused by consumption of high-fat diets can be in part related to its capacity to inhibit bile-induced NADPH oxidase and ERK1/2 activation.
Graphical abstract Image 1
Databáze: OpenAIRE